Morgan Stanley

Morgan Stanley (NYSE:MS) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/30/2024 24.7% Oppenheimer $106 → $109 Maintains Outperform 01/17/2024 21.27% Oppenheimer $107 → $106 Maintains Outperform 01/17/2024 22.41% BMO Capital $106 → $107 Maintains Outperform 01/17/2024 4.11% Keefe, Bruyette & Woods $102 → $91 Downgrades Outperform → Market Perform 01/17/2024 -0.47% JP Morgan $94 → $87 Downgrades Overweight → Neutral 01/09/2024 8.68% UBS $80 → $95 Maintains Neutral 01/09/2024 7.54% JP Morgan $92 → $94 Maintains Overweight 01/09/2024 9.83% HSBC → $96 Downgrades Buy → Hold 01/04/2024 14.4% B of A Securities $95 → $100 Maintains Buy 01/02/2024 32.71% Barclays $102 → $116 Maintains Overweight 12/21/2023 -2.76% RBC Capital → $85 Reiterates Sector Perform → Sector Perform 12/19/2023 14.4% Goldman Sachs $89 → $100 Maintains Buy 11/28/2023 -8.48% Societe Generale → $80 Downgrades Buy → Hold 11/20/2023 -2.76% Exane BNP Paribas […]

Corporate activity is likely to pick up this year, but don’t expect a sudden surge in deals just yet, Morgan Stanley CEO Ted Pick said in an interview with CNBC at Davos. There’s a ton of activity buzz so deal’s are going to happen, he said. People want to scale up and there’s a backlog of sponsor activity, so Pick thinks the pace of activity in the advisory business in particular is going to quicken, especially in the mid- to large-caps. “It’s not going to bang, but once people start getting going, I think we’re going to see a bunch of it.” He added that the U.S. is probably past peak inflation and it’s not inconceivable that the Federal Reserve cuts faster than current market pricing.

Morgan Stanley’s (MS) business diversification significantly reduced its revenue and earnings volatility compared with the financial crisis in 2008 to 2009, RBC Capital Markets said Tuesday in a report. RBC raised Morgan Stanley’s price target to $91 from $85 and kept its sector perform rating. The investment bank on Tuesday reported Q4 earnings of $0.85 per share, weighed down by certain charges, compared with $1.26 a year earlier. Revenue rose to $12.9 billion from $12.75 billion. Morgan Stanley’s core EPS was $1.15 based on RBC’s calculation, compared with $1.31 a year earlier. That beat RBC’s estimate of $0.97, mainly driven by better-than-expected net interest income and a lower-than-expected effective tax rate, according to the report. RBC raised its 2024 EPS estimate to $6.15 from $6.05 and maintained its 2025 EPS estimate of $7.55. Morgan Stanley is expected to implement stock buybacks and dividend increases using its excess capital, resulting in

Morgan Stanley (NYSE:MS) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/17/2024 2.28% JP Morgan $94 → $87 Downgrades Overweight → Neutral 01/09/2024 11.69% UBS $80 → $95 Maintains Neutral 01/09/2024 10.51% JP Morgan $92 → $94 Maintains Overweight 01/09/2024 12.86% HSBC → $96 Downgrades Buy → Hold 01/04/2024 17.56% B of A Securities $95 → $100 Maintains Buy 01/02/2024 36.37% Barclays $102 → $116 Maintains Overweight 12/21/2023 -0.07% RBC Capital → $85 Reiterates Sector Perform → Sector Perform 12/19/2023 17.56% Goldman Sachs $89 → $100 Maintains Buy 11/28/2023 -5.95% Societe Generale → $80 Downgrades Buy → Hold 11/20/2023 -0.07% Exane BNP Paribas → $85 Downgrades Outperform → Neutral 11/16/2023 21.09% Oppenheimer $98 → $103 Maintains Outperform 10/23/2023 -6.95% Odeon Capital → $79.15 Downgrades Buy → Hold 10/20/2023 — Wolfe Research Upgrades Underperform → Peer Perform 10/19/2023 14.04% Evercore ISI Group $102

Morgan Stanley (MS) on Tuesday reported weaker-than-expected fourth-quarter earnings, weighed down by certain charges, although the banking giant exceeded analysts’ expectations for revenue. Per-share earnings came in at $0.85 for the December quarter, down from $1.26 the year before and missing the Capital IQ-polled consensus of $1.03. Revenue rose to $12.9 billion from $12.75 billion, topping the Street’s view for $12.82 billion. The stock fell 3.4% in Tuesday trading. Morgan Stanley said its results were negatively impacted by a $286 million Federal Deposit Insurance Corp. special assessment to help the regulator recover losses tied to last year’s bank failures. It also recorded a $249 million legal expense that the Securities and Exchange Commission said last week would settle “fraud charges” related to certain block trades. The two charges reduced the bank’s EPS by $0.28. “In 2023, the firm reported a solid (return on tangible common equity) against a mixed market

The following is a summary of the Morgan Stanley (MS) Q4 2023 Earnings Call Transcript: Financial Performance: Morgan Stanley reported firm revenues of $54 billion with $12B of profit before tax, doubled the averages compared to ’09-’14. The client assets in their durable businesses have tripled, indicating great growth potential. A strong return on tangible common equity was recorded at 13%, even after accounting for notable items that reduced returns by over 100 points. They reported a CET1 ratio above 15%, showcasing strong capital preservation. Business Progress: Over the past 15 years, Morgan Stanley has successfully integrated with Smith Barney, acquired Solium and recent acquisitions being E*TRADE and Eaton Vance, transforming its business. Morgan Stanley is aiming for a $10 trillion asset target, indicating growth in overall wealth. The key targets include a 30% margin in wealth management and a 70% overall firm efficiency ratio, indicating focus on capital efficiency

Morgan Stanley Fourth Quarter and Full Year 2023 Earnings Results Morgan Stanley Reports Fourth Quarter Net Revenues of $12.9 Billion, EPS of $0.85 and ROTCE of 8.4%; Full Year Net Revenues of $54.1 Billion, EPS of $5.18 and ROTCE of 12.8% NEW YORK–(BUSINESS WIRE)–January 16, 2024– Morgan Stanley (NYSE: MS) today reported net revenues of $12.9 billion for the fourth quarter ended December 31, 2023 compared with $12.7 billion a year ago. Net income applicable to Morgan Stanley was $1.5 billion, or $0.85 per diluted share,(1) compared with $2.2 billion, or $1.26 per diluted share,(1) for the same period a year ago. Pre-tax income for the fourth quarter includes $535 million of charges or $0.28 per diluted share(1,2) : $286 million related to an FDIC special assessment and a $249 million legal charge related to a specific matter. Full year net revenues were $54.1 billion compared with $53.7 billion a

Morgan Stanley Q4 2023 GAAP EPS $0.85 Misses $1.00 Estimate, Sales $12.90B Beat $12.75B Estimate.

Morgan Stanley’s 4Q revenue of $12.9 billion jumps about $150 million from the prior year, with a lift from its institutional securities business leading the way. The bank says institutional securities saw net revenues for the quarter of $4.9 billion compared to $4.8 billion a year earlier, adding that investment banking revenue was up 5% from a year ago. Revenue in its wealth management business was essentially unchanged from a year ago at $6.6 billion, with the company noting that asset management revenues increased from the prior year on higher asset levels and the impact of positive fee-based flows. Investment management revenue at $1.5 billion was largely unchanged from a year earlier, with Morgan Stanley highlighting that asset management and related fees increased from the prior year on higher average assets under management driven by increased asset values.

JPMorgan analyst Kian Abouhossein maintains Morgan Stanley (NYSE:MS) with a Overweight and raises the price target from $92 to $94.

Morgan Stanley (NYSE:MS) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/02/2024 24.45% Barclays $102 → $116 Maintains Overweight 12/21/2023 -8.81% RBC Capital → $85 Reiterates Sector Perform → Sector Perform 12/19/2023 7.28% Goldman Sachs $89 → $100 Maintains Buy 11/28/2023 -14.17% Societe Generale → $80 Downgrades Buy → Hold 11/20/2023 -8.81% Exane BNP Paribas → $85 Downgrades Outperform → Neutral 11/16/2023 10.5% Oppenheimer $98 → $103 Maintains Outperform 10/23/2023 -15.08% Odeon Capital → $79.15 Downgrades Buy → Hold 10/20/2023 — Wolfe Research Upgrades Underperform → Peer Perform 10/19/2023 4.07% Evercore ISI Group $102 → $97 Maintains Outperform 10/19/2023 8.36% BMO Capital $102 → $101 Maintains Outperform 10/19/2023 5.14% Oppenheimer $100 → $98 Maintains Outperform 10/11/2023 -9.88% UBS $110 → $84 Downgrades Buy → Neutral 10/05/2023 -1.3% JP Morgan $93 → $92 Maintains Overweight 09/26/2023 7.28% Oppenheimer $105 → $100 Maintains Outperform